Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes

  title={Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes},
  author={Nelson Gomes Oliveira Junior and Marlon Henrique Silva Cardoso and Oct{\'a}vio Luiz Franco},
  journal={Cellular and Molecular Life Sciences},
Gram-positive and -negative bacteria are dangerous pathogens that may cause human infection diseases, especially due to the increasingly high prevalence of antibiotic resistance, which is becoming one of the most alarming clinical problems. In the search for novel antimicrobial compounds, snake venoms represent a rich source for such compounds, which are produced by specialized glands in the snake’s jawbone. Several venom compounds have been used for antimicrobial effects. Among them are… 

Antibacterial properties of snake venom components

Thorough investigations have shown that the phospholipases A 2 and l -amino acids oxidases (LAAO) are mainly responsible for the bactericidal properties of snake venoms, and some preliminary research studies suggest that fragments of three-finger toxins (3FTx) are bactericidal.

Insights into the Antimicrobial Activities of Unusual Antimicrobial Peptide Families from Amphibian Skin

This review will focus on the antimicrobial activities of nine recently discovered amphibian AMPs including phylloseptins, nigrocins, japonicins, palustrins, parkerins, medusins, limnonectins and hylaranins and their possible applications in human health as new alternatives to conventional medicines.

Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving

An up-to-date survey on the pharmacology of snake-venom bioactive components is shown and their therapeutic perspectives against a wide range of pathophysiological conditions are evaluated.

Antibacterial activity of selected snake venoms on pathogenic bacterial strains

The findings represent a starting point for the selection of snake venoms containing components with potential use as lead molecules in the development of new antibacterial agents, targeting multidrug resistant bacterial strains.

Harnessing snake venom phospholipases A2 to novel approaches for overcoming antibiotic resistance

This review will highlight the biochemical and structural properties of antibacterial PLA2s and peptides thereof, as well as their possible molecular mechanisms of action and key roles in development of effective therapeutic strategies.

Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs

The state of the art in snake venom-derived peptides and their therapeutic applications are described, reinforcing the potential of snake venom components as therapeutic agents, particularly in the quest for new antimicrobial and anticancer drugs.

Minor snake venom proteins: Structure, function and potential applications.

Snake venom toxins: toxicity and medicinal applications

Different non-enzymatically active snake venom toxins which have potential therapeutic properties such as antitumor, antimicrobial, anticoagulating, and analgesic activities will be discussed.

In Vitro Evaluation of Antibacterial Potential of Cerastes Vipera Venom against Gram-Positive and Gram-Negative Bacterial Strains

It could be concluded that Cerastes vipera venom is a potentially weak bactericidal, but can inhibit antibiotic-resistant bacteria as Pseudomonas aeruginosa.



Evaluation of an Antimicrobial L-Amino Acid Oxidase and Peptide Derivatives from Bothropoides mattogrosensis Pitviper Venom

A novel LAO from Bothrops mattogrosensis was isolated and biochemically characterized and showed remarkable antibacterial activity against Gram-positive and -negative bacteria, indicating a secondary protective function.

Novel therapies based on cationic antimicrobial peptides.

  • H. Pereira
  • Biology
    Current pharmaceutical biotechnology
  • 2006
Their broad spectrum activity, low potential to induce resistance and diverse functions make antimicrobial peptides an attractive family of compounds that have potential to be developed as therapeutics for treating certain infections.

Purification and characterization of a novel peptide with antifungal activity from Bothrops jararaca venom.

Coleopteran Antimicrobial Peptides: Prospects for Clinical Applications

Antimicrobial peptides (AMPs) are activated in response to septic injury and have important roles in vertebrate and invertebrate immune systems. AMPs act directly against pathogens and have both

Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins.

Omwaprin, a 50-amino-acid cationic protein from the venom of inland taipan (Oxyuranus microlepidotus), is a new member of the waprin family of snake venom proteins and shows species-specific activity on the Gram-positive bacteria tested.

Exploring the Pharmacological Potential of Promiscuous Host-Defense Peptides: From Natural Screenings to Biotechnological Applications

This review intends to construct a bridge between academic research and pharmaceutical industry, providing novel insights into the utilization of HDPs against resistant bacterial strains that cause infections in humans.

Antimicrobial peptides with cell-penetrating peptide properties and vice versa

This review summarizes recent efforts in the development of peptide-based transport systems, such as cell-penetrating peptides (CPPs), which have come into focus and their efficiency has been demonstrated in many different applications.

Bactericidal and Antiendotoxic Properties of Short Cationic Peptides Derived from a Snake Venom Lys49 Phospholipase A2

It is demonstrated that phospholipase A2-derived peptides may have the potential to counteract microbial infections and encourage further evaluations of their actions in vivo.

Structure–activity studies on magainins and other host defense peptides

In general, changes that increased the basicity and stabilized the amphipathic structure have increased the antimicrobial activity: however, as the peptides become more hydrophobic the degree of specificity decreases.

Studies on anticancer activities of antimicrobial peptides.